| Autor: |
Boersma, D., van Eekeren, R.R.J.P., Werson, D.A.B., van der Waal, R.I.F., Reijnen, M.M.J.P., de Vries, J.-P.P.M. |
| Předmět: |
|
| Zdroj: |
European Journal of Vascular & Endovascular Surgery; Mar2013, Vol. 45 Issue 3, p299-303, 5p |
| Abstrakt: |
Objective: This study evaluated the feasibility, safety and 1-year results of mechanochemical endovenous ablation (MOCA™) of small saphenous vein (SSV) insufficiency. Design: Prospective cohort study. Materials and methods: Fifty consecutive patients were treated for primary SSV insufficiency with MOCA™ using the ClariVein® device and polidocanol. Initial technical success, complications, patient satisfaction and visual analogue scale (VAS) pain score were assessed. Anatomic and clinical success was assessed at 6 weeks and at 1 year. Results: Initial technical success of MOCA™ was 100%. At the 6-week assessment, all treated veins were occluded. The 1-year follow-up duplex showed anatomic success in 94% (95% confidence interval, 0.87–1). Venous clinical severity score (VCSS) decreased significantly from 3.0 (interquartile range (IQR) 2–5) before treatment to 1.0 (IQR 1–3, P < 0.001) at 6 weeks and to 1.0 (IQR 1–2, P < 0.001) at 1 year. Median procedural VAS score for pain was 2 (IQR 2–4). No major complications were observed, especially no nerve injury. Conclusions: MOCA™ is a safe, feasible and efficacious technique for treatment of SSV insufficiency. One-year follow-up shows a 94% anatomic success rate and no major complications. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect